Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lacombe

Showing results (121-130 of 225) with videos related to

Pageof 23
Sort By:
Journal of Medical Genetics|September 22, 2001
GDNF as a candidate modifier in a type 1 neurofibromatosis (NF1) enteric phenotypeM Bahuau, A Pelet, D Vidaud, et al.
Clinical Genetics|March 18, 2017
Deletion of the transcription factor SOX4 is implicated in syndromic nephroblastomaA Trimouille, E Barouk-Simonet, S Charron, et al.
Cancer Investigation|March 20, 2003
Cancer drug development in Europe: a selection of new agents under development at the European Drug Development NetworkD Lacombe, A Butler-Smith, P Therasse, et al.
Genetic Counseling (Geneva, Switzerland)|April 7, 1999
Abdominal lymphatic dysplasia and 22q11 microdeletionT Mansir, D Lacombe, T Lamireau, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|March 15, 2011
[Polymorphic expression of epilepsy and cognitive impairment in ring chromosome 20 syndrome]F Villéga, H Ngayap, C Espil-Taris, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2005
A study from the EORTC new drug development group: open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancerW Fiedler, N Tchen, J Bloch, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2009
Targeted therapies in the treatment of advanced/metastatic NSCLCA G Pallis, L Serfass, R Dziadziusko, et al.
American Journal of Medical Genetics. Part A|November 20, 2004
Fetal presentation of PHACES syndromeD Carles, F Pelluard, E M Alberti, et al.
Genetic Counseling (Geneva, Switzerland)|September 15, 2006
A case of trisomy 12 mosaicism with pituitary malformation and polycystic ovary syndromeS Boulard, G Diene, R Barat, et al.
Neurology|March 27, 2002
Progressive bulbospinal amyotrophy in triple A syndrome with AAAS gene mutationC Goizet, B Catargi, F Tison, et al.
Pageof 23

Showing results (121-130 of 225) with videos related to

Sort By:
Pageof 23
Journal of Medical Genetics|September 22, 2001
GDNF as a candidate modifier in a type 1 neurofibromatosis (NF1) enteric phenotypeM Bahuau, A Pelet, D Vidaud, et al.
Clinical Genetics|March 18, 2017
Deletion of the transcription factor SOX4 is implicated in syndromic nephroblastomaA Trimouille, E Barouk-Simonet, S Charron, et al.
Cancer Investigation|March 20, 2003
Cancer drug development in Europe: a selection of new agents under development at the European Drug Development NetworkD Lacombe, A Butler-Smith, P Therasse, et al.
Genetic Counseling (Geneva, Switzerland)|April 7, 1999
Abdominal lymphatic dysplasia and 22q11 microdeletionT Mansir, D Lacombe, T Lamireau, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|March 15, 2011
[Polymorphic expression of epilepsy and cognitive impairment in ring chromosome 20 syndrome]F Villéga, H Ngayap, C Espil-Taris, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2005
A study from the EORTC new drug development group: open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancerW Fiedler, N Tchen, J Bloch, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2009
Targeted therapies in the treatment of advanced/metastatic NSCLCA G Pallis, L Serfass, R Dziadziusko, et al.
American Journal of Medical Genetics. Part A|November 20, 2004
Fetal presentation of PHACES syndromeD Carles, F Pelluard, E M Alberti, et al.
Genetic Counseling (Geneva, Switzerland)|September 15, 2006
A case of trisomy 12 mosaicism with pituitary malformation and polycystic ovary syndromeS Boulard, G Diene, R Barat, et al.
Neurology|March 27, 2002
Progressive bulbospinal amyotrophy in triple A syndrome with AAAS gene mutationC Goizet, B Catargi, F Tison, et al.
Pageof 23